Histopathological and molecular features of late relapses in non-seminomas

BJU International

Volumn 107, Issue 6, 2011, Pages 936-943

  Mayer, Frank ^a,d   Wermann, Hendrik ^d   Albers, Peter ^c   Stoop, Hans ^d   Gillis, Ad J M ^d   Hartmann, Jörg T ^a   Bokemeyer, C Carsten ^b   Oosterhuis, J Wolter ^d   Looijenga, Leendert H J ^d   Honecker, Friedemann ^b,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Drug resistance; Germ cell tumours; Neoplasm; Recurrence; Teratoma

Indexed keywords

B RAF KINASE; BLEOMYCIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; K RAS PROTEIN; PACLITAXEL; VINBLASTINE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; ARTICLE; CHORIOCARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; EMBRYONAL CARCINOMA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MALE; MICROSATELLITE INSTABILITY; MULTIPLE CYCLE TREATMENT; ORCHIECTOMY; PRIORITY JOURNAL; RELAPSE; SEMINOMA; TERATOMA; TESTIS NONSEMINOMA CANCER; WILD TYPE; YOLK SAC TUMOR;

EID: 79952609650     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09631.x     Document Type: Article

References (27)

1. Einhorn LH. Curing metastatic testicular cancer. Proc Natl Acad Sci USA 2002; 99: 4592-5 (Pubitemid 34286029)
2. Oldenburg J, Martin JM, Fossa SD. Late relapses of germ cell malignancies: incidence, management, and prognosis. J Clin Oncol 2006; 24: 5503-11 (Pubitemid 46631330)
3. Sharp DS, Carver BS, Eggener SE et al. Clinical outcome and predictors of survival in late relapse of germ cell tumor. J Clin Oncol 2008; 26: 5524-9
4. Oldenburg J, Alfsen GC, Waehre H, Fossa SD. Late recurrences of germ cell malignancies: a population-based experience over three decades. Br J Cancer 2006; 94: 820-7
5. Feldman DR, Bosl GJ, Sheinfeld J, Motzer RJ. Medical treatment of advanced testicular cancer. JAMA 2008; 299: 672-84 (Pubitemid 351252727)
6. Sonneveld DJ, Sleijfer DT, Koops HS, Keemers-Gels ME, Molenaar WM, Hoekstra HJ. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach. Cancer 1998; 82: 1343-51 (Pubitemid 28155397)
7. Ehrlich Y, Baniel J. Late relapse of testis cancer. Urol Clin North Am 2007; 34: 253-8 (Pubitemid 46680532)
8. Mayer F, Stoop H, Scheffer GL et al. Molecular determinants of treatment response in human germ cell tumors. Clin Cancer Res 2003; 9: 767-73 (Pubitemid 36182613)
9. Honecker F, Wermann H, Mayer F et al. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment resistant germ cell tumors. J Clin Oncol 2009; 27: 2129-36
10. Looijenga LH, Gillis AJ, Verkerk AJ, van Putten WL, Oosterhuis JW. Heterogeneous X inactivation in trophoblastic cells of human full-term female placentas. Am J Hum Genet 1999; 64: 1445-52 (Pubitemid 30468765)
11. Boland CR, Thibodeau SN, Hamilton SR et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-57 (Pubitemid 28521189)
12. Mayer F, Gillis AJ, Dinjens W, Oosterhuis JW, Bokemeyer C, Looijenga LH. Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment. Cancer Res 2002; 62: 2758-60 (Pubitemid 34525757)
13. Chen CY, Shiesh SC, Wu SJ. Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis. Clin Chem 2004; 50: 481-9
14. de Jong J, Stoop H, Gillis AJ et al. Further characterization of the first seminoma cell line TCam-2. Genes Chromosomes Cancer 2008; 47: 185-96 (Pubitemid 351162849)
15. Brice P. Managing relapsed and refractory Hodgkin lymphoma. Br J Haematol 2008; 141: 3-13 (Pubitemid 351347529)
16. Ronnen EA, Kondagunta GV, Bacik J et al. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy. J Clin Oncol 2005; 23: 6999-7004
17. Michael H, Lucia J, Foster RS, Ulbright TM. The pathology of late recurrence of testicular germ cell tumors. Am J Surg Pathol 2000; 24: 257-73 (Pubitemid 30078715)
18. Ravi R, Oliver RT, Ong J et al. A singlecentre observational study of surgery and late malignant events after chemotherapy for germ cell cancer. Br J Urol 1997; 80: 647-52 (Pubitemid 28316392)
19. Baniel J, Foster RS, Gonin R, Messemer JE, Donohue JP, Einhorn LH. Late relapse of testicular cancer. J Clin Oncol 1995; 13: 1170-6
20. Gobel U, Schneider DT, Calaminus G, Haas RJ, Schmidt P, Harms D. Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol 2000; 11: 263-71 (Pubitemid 30214662)
21. Donadio AC, Motzer RJ, Bajorin DF et al. Chemotherapy for teratoma with malignant transformation. J Clin Oncol 2003; 21: 4285-91 (Pubitemid 46621803)
22. El Mesbahi O, Terrier-Lacombe MJ, Rebischung C, Theodore C, Vanel D, Fizazi K. Chemotherapy in patients with teratoma with malignant transformation. Eur Urol 2007; 51: 1306-11
23. Bokemeyer C, Kollmannsberger C, Stenning S et al. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials. Br J Cancer 2004; 91: 683-7 (Pubitemid 39141624)
24. Horwich A, Sleijfer DT, Fossa SD et al. Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in goodprognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial. J Clin Oncol 1997; 15: 1844-52 (Pubitemid 27209513)
25. Honecker F, Stoop H, Mayer F et al. Germ cell lineage differentiation in non-seminomatous germ cell tumours. J Pathol 2006; 208: 395-400 (Pubitemid 43210526)
26. Mayer F, Honecker F, Looijenga LH, Bokemeyer C. Towards an understanding of the biological casis of response to cisplatin-based chemotherapy in germcell tumors. Ann Oncol 2003; 14: 825-32 (Pubitemid 36827197)
27. Velasco A, Riquelme E, Schultz M et al. Mismatch repair gene expression and genetic instability in testicular germ cell tumor. Cancer Biol Ther 2004; 3: 977-82 (Pubitemid 41351023)